You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR CEFDITOREN PIVOXIL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Cefditoren Pivoxil

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00598403 ↗ Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis Completed Tedec-Meiji Farma, S.A. Phase 3 2007-11-01 The main objective of the study is to comparatively assess the efficacy and tolerability of the drugs under study in the treatment of acute uncomplicated cystitis.
NCT01553006 ↗ Study of Cefditoren Pivoxil in Treatment of Childhood With Acute Rhinosinusitis Unknown status Thammasat University Phase 4 2012-01-01 Cefditoren pivoxil has been used in rhinosinusitis treatment. However, little is known about the efficacy of this drug at low and high doses.
NCT04709172 ↗ Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia Completed Meiji Pharma Spain S.A. Phase 4 2021-01-05 The global pandemic of novel coronavirus disease 2019 (COVID-19) began in Wuhan, China, in December 2019, and has since spread worldwide. The disease is mild in 85% of cases but the remaining 15% requires hospitalization and/or intensive care. Recent publications show that a significant number of COVID-19 patients are co-infected with one or more pathogens. Most co-infections occurred within 1-4 days of onset of COVID-19 disease and a considerable number of patients arrive to the Emergency rooms with mild-moderate respiratory symptoms compatible with pneumonia of presumed bacterial origin and not severe enough for requiring hospitalization. It therefore seems reasonable to adopt therapeutic strategies for these patients that are effective and easy to follow in the outpatient setting. Cefditoren (CDN) is a third-generation cephalosporin for oral administration. CDN has a broad spectrum of activity and is particularly active against the bacterial pathogens involved in community respiratory tract infections. Besides that, the use of CDN has been associated with a marked decrease in circulating levels of IL-6 and other pro-inflammatory cytokines and mediators of epithelial damage. The aim of this study is to demonstrate that CDN improves clinical condition in patients with mild-moderate COVID-19 and symptoms of bacterial pneumonia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cefditoren Pivoxil

Condition Name

Condition Name for Cefditoren Pivoxil
Intervention Trials
COVID-19 Pneumonia 1
Rhinosinusitis 1
Urinary Tract Infections 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cefditoren Pivoxil
Intervention Trials
Pneumonia 1
COVID-19 1
Sinusitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cefditoren Pivoxil

Trials by Country

Trials by Country for Cefditoren Pivoxil
Location Trials
Spain 9
Thailand 1
Greece 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cefditoren Pivoxil

Clinical Trial Phase

Clinical Trial Phase for Cefditoren Pivoxil
Clinical Trial Phase Trials
Phase 4 2
Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cefditoren Pivoxil
Clinical Trial Phase Trials
Completed 2
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cefditoren Pivoxil

Sponsor Name

Sponsor Name for Cefditoren Pivoxil
Sponsor Trials
Thammasat University 1
Meiji Pharma Spain S.A. 1
Tedec-Meiji Farma, S.A. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cefditoren Pivoxil
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.